The tumor necrosis factor receptor (TNFR) superfamily represents a growing family, with over 20 members having been identi®ed thus far in mammalian cells. These proteins share signi®cant homologies in their extracellular ligand binding domains and intracellular eector (death) domains. These receptors appear to transmit their signals via protein-protein interactions, which convey either a death or survival signal. Isolation and characterization of death domain containing proteins (TRADD, FADD/MORT-1, RIP), TRAF domain containing proteins (TRAF1-6) as well as new members and adaptor proteins such as DAXX have provided new insights to our understanding of signaling mechanisms associated with this family of receptors. While the death signals seem to be associated with the activation of both the caspase and JUN kinase pathways, the survival signals are mediated via the activation of the NF-kB pathway.
Introduction
The continued replenishment of the cellular components which comprise the hematopoietic system is dependent upon a culmination of signaling events which instruct uncommitted pluripotent stem cells to proliferate and subsequently commit themselves to dierentiate along the myeloid, lymphoid or erythroid lineages. Environmental factors such as the bone marrow microenvironment and cellular responsiveness to interleukins and cytokines were once thought to govern the establishment and maintenance of each hematopoietic lineage. Presumably, by`permitting' these soluble factors to dictate whether a cell will continue to remain in a resting state, proliferate, or terminally dierentiate, the individual constituents of the hematopoietic system are delicately and critically balanced in both cell type and number (Wyllie et al., 1980; Williams et al., 1992; Williams and Smith, 1993) . Disruptions in this physiological balance are clinically manifested in several disease states, including cancer, in which the developmental and proliferative constraints that are normally placed upon a developing cell are ignored. To avoid the onset of such defects in cellular development, cells utilize their capability to respond to additional stimuli which trigger the activation of suicidal' signal transduction pathways.
Cell death is thought to occur by two mechanisms, necrosis and apoptosis. While necrosis is believed to occur in response to physical injury, apoptosis, or programmed cell death, is a genetically encoded and tightly regulated`suicidal' process in which the cell actively participates in its own destruction. Apoptosis is morphologically characterized by membrane blebbing, cytoplasmic, nuclear and chromatin condensation, and DNA fragmentation. The cell ultimately collapses into distinct apoptotic bodies of condensed chromatin with intact membranes that display speci®c surface markers which direct neighboring phagocytic cells to engulf the vesicles before they rupture and subsequently trigger an undesired in¯ammatory immune response (reviewed in Martin et al., 1994; White, 1995) . Some of these stimuli, such as tumor necrosis factor (TNF) and some of its relatives, can provide suicidal signals via proteins containing a`death domain', while others, such as transforming growth factor beta (TGF-b) are potent and rapid inhibitors of proliferation and inducers of growth arrest and apoptosis (reviewed in Homan and Liebermann, 1994; Arch et al., 1998; Ashkenazi and Dixit, 1998) . Regulation of apoptosis is genetically controlled by numerous genes, some of which have remained highly conserved throughout evolution.
Genetic regulators of apoptosis
Genetic regulation of apoptosis has been best studied in the nematode Caenothabditis elegans (C. elegans), where it has been possible to isolate mutants that are defective in various aspects of programmed cell death. Among the 1090 cells generated during the development of C. elegans, there are 131 cells that undergo programmed cell death and the timing and identities of these cells are invariant in individual worms. Since the body of C. elegans is transparent during embryonic development, it has been possible to observe the cells undergoing apoptosis using microscopic techniques such as Nomarsi optics. Genetic analysis of mutants of C. elegans that are defective in programmed cell death has identi®ed a set of genes which act as positive and negative regulators of this biological process. Recent studies have shown that several of the genes that regulate the apoptotic pathways of C. elegans are highly conserved throughout evolution and counterparts for these genes can be readily detected in humans (Steller, 1995; Yuan, 1996) .
One of the important genes identi®ed in C. elegans by this type of genetic analysis is Ced-9, in which a dominant gain of function mutation suppresses all normal programmed cell death, while recessive loss-offunction mutation causes apoptosis in many normally living cells leading to the death of the organism.
Studies with this gene in C. elegans suggest that the product of ced-9 acts as a gatekeeper of apoptosis, where downregulation of this gene is necessary for cells to undergo programmed cell death (Yuan, 1996) . Cloning and molecular characterization of ced-9 showed that it codes for a protein of 280 amino acids, which is homologous to the mammalian protein bcl-2 (Tsujimoto et al., 1985; reviewed in Yuan, 1996; Adams and Cory, 1998) .
Two other genes which appear to be essential for the programmed cell death of C. elegans are ced-3 and ced-4 (reviewed in Yuan, 1996; Adams and Cory, 1998) . Loss of function mutations in these two genes abolish the programmed cell death of all 131 cells during C. elegans hermaphrodite development. The ced-4 gene codes for a 549 amino acid protein which contains two regions that contains two calcium binding domain known as the EF-hand. The ced-3 gene, on the other hand, codes for a protein of 503 amino acids which and was originally thought to be homologous to caspase-1 (Yuan et al., 1993) , a cysteine protease which processes interleukin-1b (IL-1b) into a mature and functional form that is required during an in¯ammatory response (Salvesen and Thornberry and Lazebnik, 1998) .
Apoptotic machinery is normally suppressed or activated by signals from the extracellular environment as well as intracellular sensors that monitor DNA damage. The absence of external survival signals or irreparable DNA damage are some of the important events that appear to trigger apoptosis in lower organisms such as C. elegans. While preserving these apoptotic responses, higher organisms such as mammals have evolved a distinctive mechanism that enables the organism to instruct certain cell populations to enter apoptotic pathways at dierent stages of development. This is well exempli®ed in the case of immune system, where it is necessary to eliminate the presence of T and B cell populations following their expansion in response to external infection (Boise and Thompson, 1996; Winoto, 1997) . To achieve this, higher organisms appear to have acquired`death receptors' that can transmit apoptic signals in response to`death ligands'. These receptors invariably seem to utilize the caspase machinery to achieve their goal of triggering cell death.
TNF and TNFR superfamilies
In 1984, two forms of TNF, TNF-a and LT-a (lymphotoxin, TNF-b), were isolated from activated macrophages and T cells, respectively. Since their identi®cation, these proteins have become representatives of a unique superfamily of ligands which currently includes the following family members: TNF, LT-a, Fas ligand (CD95L), OX40L, CD40L, CD27L, CD30L, 4-1BBL, and LTb, Apo3L/TWEAK, APO2L/TRAIL and RANKL Armitage, 1994; Gruss and Dower, 1995; Anderson et al., 1997; Ashkenazi and Dixit, 1998) . Several of the ligands are type II membrane proteins which are characterized by the con®nement of the C-terminus of the protein within the extracellular space. A 150 amino acid region within the C-terminus is actually the hallmark of the ligand family, as this is the region with which the ligands bind to their cognate receptors. In contrast to other protein families with notable homology, each of these family members displays no more than 20 ± 25% homology (which is found mostly in the extracellular region) at the protein level. Although these proteins, for the most part, exist as trimeric or multimeric membrane bound proteins which function to induce receptor aggregation, there are a few members, such as TNF and FasL, which are functional in a soluble form. Regardless of conformation, these ligands, in a mechanism analogous to other cytokines and growth factors, exert their eects through receptorligand interactions which induce downstream signal transduction events (Gruss and Dower, 1995) .
There are slightly more members of the TNF receptor (TNFR) superfamily as there are ligands with which they interact: TNF-RI (p55), TNF-RII (p75), TNF-RIII (TNF-RP) , OX-40, 4-1BB, CD40, CD30, CD27, the poxvirus gene products PV-T2 and PV-A53R, and p75 NGFR, CAR1, DR3 (also known as APO3, WSL-1, TRAMP, LARD), DR4, DR5 (also known as APO2, TRAIL-R2, TRICK 2 or KILLER) Armitage, 1994; Gruss and Dower, 1995; Ashkenazi and Dixit, 1998) . One of the most notable additions to this list is the p75 low anity nerve growth factor receptor (NGFR). While this protein was actually the ®rst family member to be identi®ed, its low-anity ligand is structurally unrelated to the TNF ligands and is therefore not included as a member of the ligand superfamily. Almost as notable are the PV-T2 and PV-A53R pox virus gene products which encode soluble homologs of the TNF receptors. The mammalian TNFR family members are type I membrane proteins and, in spite of their low degree of homology (20 ± 25%), are grouped together as such due to the presence of conserved cysteine residues in the extracellular ligand-binding domain. In general, each receptor contains varying numbers of cysteine rich domains (CRDs), each of which is characterized by the presence of approximately six cysteine residues that are interspersed within a stretch of 40 amino acids. The presence of the CRDs, based on available crystallographic data for TNF-RI, has allowed this protein superfamily to add a dierent perspective from which these (as opposed to other) growth factor receptors are studied: a functional TNF superfamily receptor is typically a trimeric or multimeric complex which is stabilized via intracysteine disul®de bonds that are formed between the CRDs of individual subunit members (Banner et al., 1993) . Despite an emphasis on the CRDs and the formation of membrane bound aggregated complexes, most receptors also exist in a soluble form. Solubility is, for the most part, achieved by proteolytic cleavage and soluble forms of TNF-RI, TNF-RII, CD27, CD30, CD40, and Fas are generated in this fashion; while 4-1BB also exists in a soluble form, it is generated via alternative splicing (Gruss and Dower, 1995) . The need for soluble forms of these receptors, as well as ligands, is currently unknown.
Irrespective of ligand and receptor conformation, both the TNF related ligands and receptors are expressed on (but are not necessarily limited to) activated T cells and macrophages and are, in one form or another, required during T cell mediated immune responses. This type of coordinated expression and function is thought to ensure that such responses, which are largely dependent upon antigen stimulation and subsequent cell-cell interactions, are initiated at the proper times, in the appropriate places, and involve the correct cell types (each of which will express either the ligand or the receptor). Frequently the outcome of such cellular responses can be quite pleiotropic, generating a broad range of cellular responses in the forms of T-cell activation and stimulation, cellular proliferation and dierentiation, or cell death in the form of cytotoxicity which proceeds by apoptosis (Armitage, 1994; Gruss and Dower, 1995) .
Death signal transduction by TNF-RI and Fas: the death domain and induction of apoptosis
The term`death domain' was originally coined in 1993 by Tartaglia et al. (1993) as a result of deletion mutagenesis studies involving TNF-RI (p55) mediated apoptotic cell death. These studies revealed that an 80 amino acid domain, which is localized to the Cterminal portion of the protein's intracellular region, is responsible for the generation of cytotoxic death signals, anti-viral responses (Tartaglia et al., 1993) , and the activation of acid sphingomyelinase (Wiegmann et al., 1994) ; it is also partially responsible for, in conjunction with residues in the N-terminal portion on the intracellular region, the induction of nitric oxide (NO) synthase activity (Tartaglia et al., 1993) . Homology searches have revealed that the TNF-RI death domain is approximately 65% similar (28% identical) to a 65 amino acid region within the intracellular domain of the Fas antigen; mutagenesis studies have con®rmed that these 65 amino acids are required for the induction of cell death following treatment with an anti-Fas antibody in conjunction with actinomycin D (Itoh and Nagata, 1993) . Supporting evidence for a functional overlap between the domains of these two receptors was achieved through the generation of a`death signal delivering' chimeric receptor which replaced TNF-RI amino acid residues 324 ± 426 with the corresponding amino acids of the Fas antigen (Tartaglia et al., 1993) .
The death domain, aside from being the only homologous intracellular domain that is shared by members of the TNFR superfamily, generates a cytotoxic signal irrespective of its position with respect to the extracellular domain (Tartaglia et al., 1993) . In addition, this domain appears to mediate self-association of both TNF-RI and Fas, thereby mimicking the aggregation events which are induced by ligand binding to each of these receptors (Boldin et al., 1995a) . These results, which demonstrate that the death domain is an independent domain at both the structural and functional levels, were recently con®rmed by the identi®cation and subsequent characterization of three death domain-containing proteins, each of which can generate an apoptotic signal when overexpressed in cells.
Transducers of death: novel mediators of TNF-RI signal transduction
The rapid induction of cell death via the death domain is thus far unique to TNFR superfamily; however, despite the characterization of a de®ned`death inducing' region within each of these receptors, the intermediates involved in the transmission their signals were, until recently, completely unknown. As with other receptors which are devoid of catalytic activity, TNF-RI and Fas were suspected to utilize cellular proteins as`downstream messengers of death'. Many charged residues that are well conserved in both proteins were suspected to be widely dispersed throughout portions of the death domains which are oriented to interact with protein components of the cytoplasm (Tartaglia et al., 1993) . To date, several death domain-containing proteins which associate with either TNF-RI or Fas have been identi®ed and characterized with respect to their ability to induce apoptosis and other downstream signaling events which are activated in immune responses achieved through ligand binding to this receptor.
TRADD: a TNF-RI-associated protein
Although TNF can bind to both TNF-RI and TNF-RII, the former appears to be responsible for the generation of most of the knowledge surrounding TNF-mediated cellular responses. TRADD, a novel gene product having little or no homology with other known proteins in the database, was one of the ®rst of several TNF-RI-associated proteins identi®ed (Hsu et al., 1995) . Although levels of TRADD expression in most tissues examined are relatively low, the 1.5 kb TRADD message, as well as that of TNF-RI, are ubiquitously expressed. Deletion mutagenesis of this oligomeric 34.2 kDa protein has suggested that interaction with TNF-RI via residues of the TNF-RI death domain is mediated by a C-terminal 111 amino acid TRADD death domain. The TRADD death domain also appears to modulate TRADD selfassociation, NF-kB activation and induction of apoptosis. This region (residues 195 ± 305) is 23% identical to that of TNFR-I, but shares only 13% identity with that of Fas. Despite the fact that a chimeric TNF-RI protein which contains a Fas death domain can initiate an apoptotic response, the death domain of Fas is unable to associate with TRADD. These results, in conjunction with others which have suggested a divergence in TNF and Fas mediated apoptotic pathways, further demonstrate the uniqueness and individuality of each receptor despite the presence of a death domain. Overexpression of TRADD induces a similar CrmA-inhibitable apoptotic phenotype as TNF-RI overexpression, including an alteration in cell morphology and DNA fragmentation (Hsu et al., 1995) .
FADD /MORT-1 and RIP
FADD (designated MORT-1 by Boldin et al. (1995b) , who simultaneously isolated the identical cDNA) is another addition to the rapidly growing list of death domain-containing proteins; the protein is appropriately named given that it shares many characteristics with TRADD. First, the 1.6 kb FADD/MORT-1 message is ubiquitously expressed (as is that of the Fas antigen). Like TRADD, FADD, with a molecular weight of 23.3 kDa, appears to be highly selective in its interactions in that it strongly associates with Fas via death domain-death domain interactions. In addition, FADD is also able to associate with TNF-RI (Chinnaiyan et al., 1995) , and therefore explains some of the similarities between TNF-RI and Fas-mediated apoptosis.
Database searches have revealed that the FADD death domain shares 25 ± 30% identity with those of TNF-RI and Fas; more importantly, amino acid residues 111 ± 170 within the death domain of human FADD/MORT-1 are identical to amino acid residues 233 ± 292 of rat Fas (rFas) which localize to the death domain of the protein. Since it has been previously stated that Fas and TNF-RI can self-associate, and that this association is via the death domain, it may be that the death domain may actually be a domain which is required for protein-protein interactions (Boldin et al., 1995b; Chinnaiyan et al., 1995) , thus facilitating the signal transduction pathways that lead to apoptosis. In fact, Chinnaiyan et al. (1995) and others (Feinstein et al., 1995) have remarked that a death domain has been found in various other proteins such as ankyrin, a protein involved in cell adhesion and cell-cell interactions. Analogous to TRADD, overexpression of FADD/MORT-1 can induce apoptosis which is inhibitable by CrmA. However, what appears to be particularly unique about FADD/MORT-1 is that the eector domain which actually induces apoptosis resides at the N-terminus of the protein (the death domain with which Fas interacts is located at the Cterminus).
FADD couples the TNF-RI-TRADD and Fas-FADD complexes to activation of Caspase-8, by recruiting pro-caspase-8 to the receptor complex. FADD appears to accomplish this important task via a`death eector domain' that binds to an analogous domain in pro-caspase-8 (also called a FLICE or MACH) (Boldin et al., 1996; Muzio et al., 1996) . This interaction domain, also known as CARD (caspase recruitment domain), is found in a large number of caspases including Caspase-2, 8, 9 and 10 (Homann et al., 1997) . The recruitment of pro-caspase-8 appears to result in its oligomerization, activation of its autoproteolytic activity and ultimately the generation of enzymatically active caspase-8 (Yeh et al., 1998; Zhang et al., 1998) . Activated caspase-8 is known to cleave other pro-caspases, such as caspase-9 (the functional homolog of CED3), thereby initiating apoptosis. Besides FADD, TNF-RI can engage an adapter called RAIDD or CARDD. RAIDD associates with the death domain of RIP, and through a CARD motif, associates with caspase-2, thereby inducing apoptosis.
Studies with FADD null mutant mice demonstrate that FADD is essential for normal development as FADD7/7 mice are embryonic lethal (Yeh et al., 1998; Zhang et al., 1998) . While the T cells derived from these mice are resistant to Fas-mediated apoptosis, they seem to exhibit defects in antigen induced proliferation suggesting that FADD is associated with other critical functions besides apoptosis.
Recently, a family of viral proteins called v-FLIPs and their cellular homologs, termed c-FLIPs have been described, whose function is at present unclear. Since these proteins contain a death eector domain, it is possible that they perform functions analogous to those of FADD (Thome et al., 1997; Shu et al., 1997; Hu et al., 1997) .
Daxx and JNK pathway
In addition to the activation of caspase-8, Fas-ligand interactions appear to activate apoptosis by a second mechanism which involves activation of the Jun kinase cascade, culminating in the phosphorylation and activation of transcription factors such as c-Jun. This second pathway appears to be mediated by a novel protein termed Daxx, which binds to the death domain of Fas via its C-terminal end (Yang et al., 1997) . Overexpression of Daxx was found to enhance Fasmediated apoptosis and activation of the JNK pathway. Recent analysis of the mechanisms associated with Daxx-mediated apoptosis revealed that this protein interacts with the N-terminal 648 amino acids of Ask1 (a MAP3K). Based on their deletional mutagenesis studies, Chang et al. (1998) propose that ASK1 normally exists in an inactive state because of the intra-molecular interaction between the N-and Cterminal ends of this protein. Recruitment of Daxx to the Fas receptor complex facilitates its interaction with Ask1, resulting in the`opening up' of the ASK1 kinase into an active conformation. Activated ASK1 appears to initiate a phosphorylation cascade that ultimately results in the phosphorylation of c-Jun N-terminal kinase, JNK. c-Jun, the JNK substrate, has been shown to activate apoptotic pathways by a mechanism that is yet to be determined.
Survival signals transduced by TNF-RI
One of the earlier intriguing observations concerns the activation of NF-kB by TRADD, a phenomenon which is also associated with TNF-R1 engagement and is involved in TNF-mediated responses (reviewed in Heller and Kronke, 1994; Ashkenazi and Dixit, 1998) . Unlike the TRADD-induced apoptotic response, NF-kB activation is not inhibited by CrmA (Hsu et al., 1995) . It has been known for some time that TNF-R1 rarely triggers apoptosis unless protein synthesis is blocked (Itoh and Nagata, 1993) , suggesting the existence of signaling pathways that can suppress apoptotic stimuli generated by this receptor-ligand interactions. Recent studies have determined that indeed activation of NF-kB is a survival signal that is transmitted by some of the death receptors.
TNF-RI-mediated induction of cell survival appears to involve a second receptor-associated protein, designated RIP (receptor interaction protein) (Stanger et al., 1995) . Although its pattern of expression is also constitutive and increases in conA activated T cells, the structure of the 74 kDa RIP protein is somewhat unique from the others which have been discussed here. Despite the presence of a death domain which is most closely related to that of TNF-RI (30% identical; 59% similar) at the C-terminus of the protein, the Nterminus of the protein displays the characteristics of a kinase domain, which shares key residues in common with the serine-threonine family kinases, suggesting that the encoded protein might function as a serine/ threonine kinase. Accumulating evidence suggests that ligand-induced trimerization of the TNF-RI results in the recruitment of the death domain adaptor protein TRADD, which in turn recruits RIP. RIP interacts with TRADD via its death domain, and this interaction appears to be TNF-dependent Kelliher et al, 1998) . Over-expression of RIP induces NF-kB Ting et al., 1996) as well as JNK activation. In addition, dominant negative forms of RIP have been shown to speci®cally inhibit TNFa-induced NF-kB and JNK activation. While the role of JNK activation in this process is unclear, activation of NF-kB has recently been shown to be associated with cell survival (Beg and Baltimore, 1996; Liu et al., 1996; Van Antwerp et al., 1996; Wang et al., 1996) ; however, the mechanisms, by which RIP activates this transcription factor is not entirely clear. NF-kB proteins are a family of cytoplasmic heterodimeric transcription factors that are inactive due to their association with an inhibitory protein, termed IkB (reviewed in Gilmore et al., 1996) . Upon phosphorylation by IKKa and IKKb, IkB becomes ubiquitinated and degraded by proteosome complexes (Zandi et al., 1997) . Once free, unbound NF-kB dimerizes and becomes an active transcription factor that translocates to the nucleus and activates transcription of NFkB-responsive genes. IKKs are phosphorylated by NIK (NF-kB-inducing kinase), a MAP kinase that is part of the TNF-RI receptor complex (reviewed in Gilmore et al., 1996; Malinin et al., 1997) . According to this model, TNF-RI activation may stimulate RIP kinase activity, which then phosphorylates NIK, which in turn, activates IKKa and IKKb. This could lead to Ik-B phsophorylation and degradation, resulting in the activation of NF-kB. This model is supported by the analysis of RIP7/7 cells, which are defective in TNFinduced NF-kB activation. Interestingly, these cells retain TNF-mediated JNK activation, suggesting that RIP may not be directly involved in the activation of JNK (Kelliher et al., 1998) . This observation poses a problem in explaining earlier results, where Hsu et al. (1996) have shown that dominant negative mutants of RIP block activation of both NF-kB and JNK. This model also does not explain how a kinase-defective RIP mutant restores the NF-kB inducibility in a RIPde®cient JURKAT clone (Ting et al., 1996) . Additional studies with RIP7/7 cells are required to resolve these discrepancies.
Clinical relevance of FADD/MORT-1 and RIP interactions with the Fas death domain are evident when viewed in the context of Fas alleles which contain the lymphoproliferation (lpr) and lpr cg mutations, both of which abolish the ability of Fas to transduce apoptotic signals. Mice which inherit these alleles display phenotypic characteristics which resemble the autoimmune disease state of systemic lupus erythematosus (SLE), autoantibody production, and increased levels of immunoglobulins (Nagata and Goldstein, 1995) . Neither FADD/MORT-1 nor RIP is able to interact with the lpr and lpr cg alleles respectively, further con®rming that these mice (and perhaps those patients suering from disease states which are mimicked by the lpr mice (Fisher et al., 1995) ) are unable to mediate the downstream signal transduction events which are required for the proper elimination of certain lymphocytes which, under normal circumstances, are removed in a timely fashion following activation (Boldin et al., 1995b; Chinnaiyan et al., 1995; Stanger, et al., 1995) .
TRAF proteins: the ®rst isolated TNFR superfamily associated proteins
Despite the recent attention received by the receptor associated proteins of TNF-RI and Fas, the receptor associated proteins of the less commonly studied TNF-RII (p75) protein were actually the ®rst TNFR superfamily associated proteins to be identi®ed. It was known early on that activation of TNF-RII results in the activation of NF-kB. Deletional mutagenesis has determined that a C-terminal 78 amino acid region is responsible for the generation of signals which are sucient to induce cellular proliferation and NF-kB activation. Since the entire intracellular region of TNF-RII, like those of TNF-RI and Fas, does not possess any domains with intrinsic catalytic activity, receptor associated proteins were thought to function as the actual signal transducers during TNF-RII generated signals. Experiments aimed at the identi®cation and characterization of these proteins resulted in the isolation of two novel proteins, termed TRAF-1 (TNF receptor-associated factor-1) and TRAF-2 (Rothe et al., 1994) . Since then, six distinct TRAF proteins (termed TRAF-1 through 6) have been identi®ed in mammalian cells (reviewed in Arch et al., 1998) .
All TRAF proteins share several structural motifs. TRAFs range in size from 409 amino acids (TRAF-1) to 567 amino acids (TRAF-3) and contain distinct domains (reviewed in Arch et al., 1998 and references therein). The C-termini of the proteins, which has been designated by Rothe et al. (1994) as the TRAF domain, is further divided into two sub-domains. The C-terminal portion of the TRAF domain is highly conserved between TRAF proteins and appears to be unique to TRAF domain containing proteins. The Nterminal portion of the TRAF domain is somewhat less conserved, and appears to conform to the coiled-coil a helix motif (Rothe et al., 1994) . While it is possible that the coiled-coil may account for the oligomeric qualities of TRAFs, additional experiments have implicated the more conserved C-terminal TRAF domain sequences in protein oligomerization in addition to their function in mediating TRAF protein-receptor interactions (Cheng et al., 1995; Hu et al., 1995; Mosialos et al., 1995; Rothe et al., 1995; Sato et al., 1995) .
All of TRAFs, with the exception of TRAF-1, share a few characteristics with some more commonly known transcription factors. The N-terminus of these proteins contains a RING ®nger motif which is believed to mediate both DNA-protein as well as protein-protein interactions via the formation of two zinc ®nger structures. TRAF-2,3,4,5 and 6 also contain a zinc®nger domain consisting of ®ve zinc ®nger structures. The zinc ®nger domain of TRAFs is most closely related to that of TFIIIA and the presence of one or both of these domains may implicate TRAFs in signal transduction events occurring in the cytoplasm as well as the nucleus. Interestingly, TRAF-3 and TRAF-5 contain an isoleucine zipper domain between the last zinc ®nger and the TRAF-N domain. With the exception of TRAF-4, all of the TRAFs have been found to be localized in the soluble fraction of the cytosol. TRAF-4, on the other hand appears to be a nuclear protein, and interestingly has not been shown to associate with any of the TNF family of receptors.
Both a heteromeric complex composed of TRAF-1 and TRAF-2 as well as TRAF-2 homodimers can associate with the C-terminal signal transducing component of TNF-RII; although TRAF-1 is also capable of forming homodimers, association with TNF-RII appears to be mediated by TRAF-2. Additional use of the yeast two hybrid system has determined that although TRAF-2 can bind strongly to TNF-RII and TRAF-1, interaction between TRAF-1 and the receptor is relatively weak. These, as well as other deletion experiments suggest that the interaction between TRAF-1 and TNF-RII, is likely to be dependent upon its heterodimerization with TRAF-2. More importantly, the TRAF domain, like the death domain, appears to constitute an yet another unique protein dimerization motif which functions to mediate the protein aggregation events that are required to initiate downstream signal transduction pathways (Rothe et al., 1994 Cheng et al., 1995; Hu et al., 1995; Mosialos et al., 1995; Sato et al., 1995) . Interestingly, Northern blot analysis reveals the expression of the 2.2 kb TRAF-2 transcript in most tissues, with the highest levels being observed in the spleen. The 2.1 kb TRAF-1 transcript, on the other hand, is only detected in the spleen, testis, and lung. In those tissues where multiple TRAF proteins are expressed, they may heterodimerize and form a functional signal transducing component; however, in those tissues where only TRAF-2 is expressed alone, it may form a homodimer which can function as a sole signal transducing component of TNF-RII (Rothe et al., 1994) .
Role of TRAFs in TNFR-mediated signal transduction
During the past few years, several groups have examined the role of TRAFs in signal transduction by examining the nature of intracellular kinases that are activated as a consequence of over-expression of TRAFs. These studies have shown that overexpression of TRAF-2, 5 and 6 activate the JNK and NF-kB pathways (reviewed in Arch et al., 1998) . Neither of these pathways appear to be activated by overexpression of TRAFs 1, 3 and 4 suggesting that dierent TRAFs, in spite of their structural homology, might perform very dierent functions. In a recent study, Dadgostar and Cheng (1998) examined the molecular basis for the dierent biochemical activities observed between TRAF-3 and TRAF-5. Taking advantage of the high degree of structural similarity between TRAF-5, which activates both NF-kB and JNK, and TRAF-3, which activates neither, they constructed a number of chimeric molecules by domain swapping between the two cDNAs. Their result demonstrate that the structural basis for the dierences in signaling by TRAF-3 and TRAF-5 can be overcome by replacing the ®rst zinc ®nger and ®rst 10 amino acids of the second zinc ®nger of TRAF-3 with those of TRAF-5.
In addition to the six TRAFs, the TRAF-2 gene was found to code for an alternatively spliced form designated as TRAF-2A, which diers from TRAF-2 in that it contains a seven amino acid insertion in its ring ®nger domain. Interestingly, over-expression of TRAF-2A failed to activate the NF-kB pathway, while activating the JNK pathway (Dadgostar and Cheng, 1998) . These results implicate the existence of pathwayrestricted TRAFs and demonstrate that these two signal transduction pathways could be dierentially regulated by minor alterations in the structure of TRAFs.
JNK, which activates the transcription factor c-Jun by phosphorylation at its amino terminal end, is itself activated by phosphorylation which is mediated by a MAP kinase (MAPKK/SEK/MEK). MEK, in turn is activated by phosphorylation by a MAPKK, termed MEKK1 (reviewed in Dhanasekaran and Reddy, 1998) . MEKK1 is activated through phosphorylation by GCKR protein (Germinal Center Kinase Related Protein) (Shi and Kehrl, 1995) . Dominant negative mutants of MEKK1 and GCKR block the TRAFmediated activation of JNK suggesting that TRAF-2 might mediate activation of this pathway at a very proximal step. None of these kinases were shown to associate with TRAF-2. However, recently showed that ASK1 interacts with members of the TRAF family and is activated by over-expression of TRAF-2, 5 and 6. A dominant negative mutant of TRAF-2, which inhibits JNK activation by TNF, also was found to block TNF-induced ASK1 activation. In addition, a kinase negative mutant of ASK1 was found to act as dominant negative inhibitor of TNF and TRAF-2-induced activation of JNK. Since ASK1 rapidly associates with TRAF-2 in a TNF-dependent manner, this kinase acts as an important intermediary kinase associated with the activation of both the JNK and NF-kB activation pathways.
As can be expected, TRAF-2-de®cient mice fail to activate JNK in response to TNF (Yeh et al., 1997) . Surprisingly, however, these cells seem to activate the NF-kB pathway in the absence of TRAF-2. These results suggest that TRAF-2 is not essential for NF-kB activation. It is possible that other TRAFs compensate for the loss of TRAF-2 in these cells; alternatively other pathways, such as those associated with RIP might also by compensatory. Dominant negative forms of TRAF-2 were also found to block TNF-mediated activation of NF-kB. The mechanisms by which TRAFs activate NF-kB remains to be solved. Recently, TRAF-2 was found to interact with NIK, suggesting that TRAFs could directly activate this kinase.
TRAF-3 and CD40 interactions
Characterization of TRAF-3 (CRAF-1, CAP-1, CD40 bp, LAP-1) has provided additional information regarding the mechanisms by which TRAFs dimerize and transduce signals (Cheng et al., 1995; Hu et al., 1995; Mosialos et al., 1995; Sato et al., 1995) . The 62 kDa TRAF-3 protein, like TRAF-2, is expressed in virtually all tissues examined to date. Despite the fact that receptor-protein interaction occurs via a CD40 sub-domain which shares a low degree of homology with regions within TNF-RI, Fas, and the p75 subunit of NGFR, an overall anity for the 62 amino acid intracellular region of CD40 presumably accounts for a more speci®c involvement in CD40L (Cheng et al., 1995; Hu et al., 1995; Mosialos et al., 1995; Rothe et al., 1995; Sato et al., 1995) , and possibly LTb (Mosialos et al., 1995; Force et al., 1997) and OX-40 ligand-induced signal transduction pathways (Arch and Thompson, 1998; Kawamata et al., 1998) .
The majority of CD40 mediated signal transduction knowledge originates from studies involving CD40 which is expressed on the surface of B lymphocytes. CD40 is activated upon binding to the CD40L (gp39) protein which is present on the surface of immune system constituents such as helper T cells. Although CD40L mediated engagement of CD40 protects B lymphocytes from Fas mediated apoptosis, it also induces B cell proliferation and dierentiation, expression of several cluster of dierentiation antigens such as CD23 and CD80 (BB-1 or B7), generation of memory B cells, and isotype switching. The pleiotropic nature of this interaction is further complicated by the fact that CD40, which is expressed at all stages of B cell dierentiation with the exception of plasma cells, exerts varying eects at dierent stages of the B lymphocyte maturation process. Clinical evidence which supports these ®ndings as well as stresses the importance of CD40 is found in individuals with mutations in the CD40L gene. Genetic lesions within CD40L, like Fas and FasL, wreak havoc on cells of the immune system. Disruption of CD40L:CD40 interactions results in an X-linked immunode®ciency syndrome (X-linked hyper-IgM syndrome) which is characterized by the absence of lymphoid follicles as well as increased levels of IgM and the absence of IgG, IgE, and IgA due to an inability to undergo isotype switching (reviewed in Conley, 1994; Gruss and Dower, 1995; Cheng et al., 1995) .
Because TRAF-3 is expressed during all stages of B lymphocyte dierentiation (Cheng et al., 1995) , the consequences of its interaction with CD40 are diverse. It will be of equal interest to determine the roles of TRAFs 1, 2 and 6 in CD40 generated immune responses, as these proteins have also been shown to interact with CD40 (Pullen et al., 1998) , and can transduce dierent signals form other TNFR family than TRAF-3. Residues which comprise the N-terminal RING ®nger domain are of paramount importance with respect to NF-kB activation (which is also observed upon overexpression of the TRAF-2 protein). In a manner analogous to death domain mediated receptor aggregation, it is thought that overexpression of TNFR superfamily associated proteins mirrors the phenomenon of ligand-induced receptor aggregation . Unlike the activation eects induced by TRAF-2 in both TNF-RII and CD40 generated signals, TRAF-3 appears to negatively regulate protein activation and expression since overexpression of TRAF-3 suppressed TNF-RII and CD40-dependent activation of NF-kB dependent reporter genes in 293 cells. This has been further supported by studies in which dominant negative mutants of TRAF-3 did not eect NF-kB activation and only weakly eected JNK activation (Grammer et al., 1998) . Because these mutants have been shown to inhibit p38 activation and immunoglobulin production, CD40 may utilize other TRAFs to which it binds to transduce speci®c signals for NF-kB activation (Grammer et al., 1998) . It has also been hypothesized that the RING ®nger domain of this protein is also able to modulate downstream events, as an N-terminal deletion mutant of TRAF-3 has been observed to suppress CD40 dependent induction of CD23 (Cheng et al., 1995; Rothe et al, 1995) . Dominant negative TRAF-3 mutants have also been shown to block LT-binduced apoptosis (Force et al., 1997) .
At the protein level, TRAF-3 is most closely related to TRAF-2; however, the most notable dierence is the presence of an isoleucine zipper which is located between the N-terminal RING and zinc ®nger domains and the C-terminal TRAF domain in TRAF-3 (Cheng et al., 1995) . The presence of an isoleucine zipper, either alone or in conjunction with the other domains which have been previously identi®ed in transcription factors, is again indicative of a protein directly linking cytoplasmic generated signals to those occurring in the nucleus. CD40:TRAF-3 and TRAF-3: TRAF-3 interactions occur via the Cterminal portion of the TRAF domain (Cheng et al., 1995; Hu et al., 1995; Mosialos et al., 1995; Sato et al., 1995) . Although these results clearly indicate that the residues within the TRAF domain (which in contrast to the N-terminal TRAF domain residues are unique to, and are well conserved among members of the family) constitute a protein dimerization motif, they do not completely account for the speci®city of interaction among family members. While both TNF-RII and CD40 utilize TRAF-2, each protein appears to preferentially recruit other TRAFs in order to generate signals which are partially distinct and non-overlapping. Exactly what accounts for the speci®city of interactions between closely related members of a protein superfamily remains to be elucidated.
Although the mechanisms of protein dimerization among these proteins is not clear, the identi®cation of TRAF proteins, in addition to enriching our understanding of TNFR superfamily signal transduction pathways, has also allowed us to gain insight into the mechanisms which are used by the Epstein Barr Virus (EBV) (the causative agent of infectious mononucleosis) to immortalize B lymphocytes. During life cycle of the virus, expression of the latent infection membrane protein (LMP1) and other viral gene products are crucial for B cell transformation. LMP1, which also transforms non-lymphoid cells, induces the majority of molecular characteristics observed in EBV positive cells including NF-kB activation, altered surface marker expression, and possibly the abrogation of requirements for certain growth factors (Mosialos et al., 1995) . LMP1 is an integral membrane protein which contains six hydrpohobic transmembrane domains that are required for protein aggregation at the plasma membrane. TRAF-1, 2, 3 and 5 are expressed in EBV positive B lymphoblasts (Devergne et al., 1998) . TRAF-3 interacts with the ®rst 44 amino acids of the LMP1 C-terminus through residues within the TRAF domain. (The C-terminus of the protein is responsible for induction of the transformed state). As with CD40, altered expression of TRAF-3 mutants do not eect NF-kB activation by LMP1 (Miller et al., 1997) , and in fact, LMP1-induced NF-kB activation and TRAFmediated signaling are presumed to travel via independent pathways (Miller et al., 1997) through dierent LMP1 motifs (Brodeur et al., 1997) . Because it is presumed that LMP1 sequesters TRAF proteins at the plasma membrane, its expression may mimic the eects induced by members of the TNF superfamily such as CD40 (which, in conjunction with IL-4 treatment of primary B cells, induces the characteristics of EBV transformed cells) and LTb (Mosialos et al., 1995) .
In addition to members of the TNFR superfamily and other death domain-containing proteins, TRAF proteins are also able to associate with other regulatorỳ modifying' proteins that can subvert TRAF-mediated responses (reviewed in Arch et al., 1998) . Proteins that fall into this class include c-IAP1 and 2, TRIP, TANK/ I-TRAF and A20. By associating with members of the TRAF family, these proteins have been shown to block TRAF-mediated NF-kB activation and/or apoptosis, depending on the cell type in which they are expressed and the signals by which they are induced. The precise mechanisms of activation of these proteins is ate present unclear.
New members of the TNFR superfamily: DR3, DR4, DR5 and the identi®cation of decoy receptors
The newest members of the TNFR superfamily, DR3, DR4, DR5 and RANK were only isolated in the past two years (reviewed in Ashkenazi and Dixit (1998) and Figure 1 Schematic representation of the proposed interactions between selected members of the TNFR superfamily and their associated proteins references therein). DR3, which shares the most homology with TNF-RI, can induce apoptosis as well as NF-kB activation using TNF-RI-analogous pathways in response to ligand (Apo3L/TWEAK) binding. DR4, which shares the most homology with Fas, induces apoptosis along the caspase-8-mediated pathway when bound to its ligand, Apo2/TRAIL. While this pathway is analogous to Fas-mediated apoptosis, it is at present unclear as to whether FADD is required in DR4-mediated signaling. Apo2L/TRAIL also bind to DR5, and it is presumed that ligand activation of this receptor triggers signaling pathways that are closely related to that of DR4. Interestingly, DR4 and DR5-mediated signaling can be modulated by Apo2L/TRAIL interactions with decoy receptors that compete with DR4 and 5 for ligand binding. There are currently two decoy receptors, DcR1 and DcR2. DcRI (LIT/TRID/TRAIL-R3) is structurally similar to both DR4 and 5 is GPI-linked to the outer surface of the plasma membrane. Unlike DR4 and 5, DcR1 lacks an intracellular domain and therefore is incapable of transducing DR4 or DR5-like signals. DcR2 (TRUNDD/TRAIL-R4) also shares structural relatedness to DR4 and 5, but has a smaller death domain that lacks the regions that are responsible for the induction of apoptosis and NF-kB activation.
Conclusions
Delineation of the signal transduction pathways associated with the signals mediated by the TNFR superfamily have demonstrated the nature of pleiotropic responses generated by these receptors through their interaction with multiple components of cellular machinery. As depicted in Figure 1 , all of these receptors appear to activate apoptotic pathways via the activation of the caspase cascade. These studies, which focused on the ability of the TNF-RI and Fas death domains to induce apoptosis, resulted in the identi®cation of additional death domain-containing proteins (TRADD, FADD/MORT-1, RIP) which are capable of inducing apoptosis when overexpressed in cells. Not only have these discoveries allowed investigators to further dissect the signal transduction pathways which are mediated by these receptors, they further con®rm preliminary results which suggested that the death domain may actually be a dimerization motif. Presumably protein multimerization via the death domain allows for the aggregation of signal transducers and the subsequent engagement of downstream targets, the most important of which is procaspase-8, whose dimerization activates its proteolytic activity and other participants in the caspase cascade.
Another variation is seen in the activation of the JNK pathway, which is often associated with stressinduced apoptosis. TNFR family receptors appear to activate this pathway by multiple mechanisms which are mediated by dierent cellular proteins that are recruited to the receptors following their oligomerization. This is exempli®ed by the DAXX-ASK and TRAF-2-ASK connection, both of which appear to activate the JUN kinase pathway. Interestingly TRAFs, which exhibit extensive structural homology amongst themselves, seem to function primarily as transducers of survival signals via activation of the NF-kB pathway. The TRAF proteins were originally identi®ed and characterized with respect to their ability to bind to TNF-RII (as well as to each other) via a novel domain, the TRAF domain. While the resulting phenotype associated with the overexpression of these proteins is rather pleiotropic, they appear to modulate the expression of genes which often lead to the induction of an immune response and the maturation of those cells which contribute to these responses. While the exact mechanism by which TRAF proteins activate NIK or ASK1 is at present unclear, further study of these proteins at the biochemical and molecular levels should aid in the understanding of immune system development and the nature of the signaling pathways that induce immune system constituent proliferation, dierentiation, and removal following activation. It is intriguing that TRAFs often mediate the activation of both the JNK and NF-kB pathways. It appears that when these receptors activate the JNK pathway alone, the phenotypic result appears to be cell death. In contrast, the activation of both the NF-kB and JNK pathways appear to result in cell survival, suggesting that the target genes of c-Junassociated complexes could be quite dierent in the presence or absence of activated NF-kB. Additional studies aimed at understanding the target genes of these two important transcription factors that mediate survival and death could provide us with important clues regarding cell proliferation, dierentiation, and death following activation of the death receptors.
